These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7993077)

  • 21. Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening.
    Niyomrattanakit P; Wan KF; Chung KY; Abas SN; Seh CC; Dong H; Lim CC; Chao AT; Lee CB; Nilar S; Lescar J; Shi PY; Beer D; Lim SP
    Antiviral Res; 2015 Jul; 119():36-46. PubMed ID: 25896272
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin.
    Guyatt KJ; Westaway EG; Khromykh AA
    J Virol Methods; 2001 Mar; 92(1):37-44. PubMed ID: 11164916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.
    Farias KJ; Machado PR; da Fonseca BA
    ScientificWorldJournal; 2013; 2013():282734. PubMed ID: 23431254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening.
    Pattnaik A; Palermo N; Sahoo BR; Yuan Z; Hu D; Annamalai AS; Vu HLX; Correas I; Prathipati PK; Destache CJ; Li Q; Osorio FA; Pattnaik AK; Xiang SH
    Antiviral Res; 2018 Mar; 151():78-86. PubMed ID: 29274845
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Strategies for the treatment of dengue virus infections: a narrative account.
    De Clercq E
    Future Med Chem; 2010 Apr; 2(4):601-8. PubMed ID: 21426010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The dengue virus NS5 protein as a target for drug discovery.
    Lim SP; Noble CG; Shi PY
    Antiviral Res; 2015 Jul; 119():57-67. PubMed ID: 25912817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of Potent Non-nucleoside Inhibitors of Dengue Viral RNA-Dependent RNA Polymerase from Fragment Screening and Structure-Guided Design.
    Lim SP; Noble CG; Nilar S; Shi PY; Yokokawa F
    Adv Exp Med Biol; 2018; 1062():187-198. PubMed ID: 29845534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
    Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
    PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Geraniin extracted from the rind of Nephelium lappaceum binds to dengue virus type-2 envelope protein and inhibits early stage of virus replication.
    Abdul Ahmad SA; Palanisamy UD; Tejo BA; Chew MF; Tham HW; Syed Hassan S
    Virol J; 2017 Nov; 14(1):229. PubMed ID: 29162124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp.
    Coulerie P; Nour M; Maciuk A; Eydoux C; Guillemot JC; Lebouvier N; Hnawia E; Leblanc K; Lewin G; Canard B; Figadère B
    Planta Med; 2013 Sep; 79(14):1313-8. PubMed ID: 23929244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of dengue virus infection by mannoside glycolipid conjugates.
    Schaeffer E; Flacher V; Neuberg P; Hoste A; Brulefert A; Fauny JD; Wagner A; Mueller CG
    Antiviral Res; 2018 Jun; 154():116-123. PubMed ID: 29630976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of a dengue NS4B inhibitor originating from an HCV small molecule library.
    Hernandez-Morales I; Geluykens P; Clynhens M; Strijbos R; Goethals O; Megens S; Verheyen N; Last S; McGowan D; Coesemans E; De Boeck B; Stoops B; Devogelaere B; Pauwels F; Vandyck K; Berke JM; Raboisson P; Simmen K; Lory P; Van Loock M
    Antiviral Res; 2017 Nov; 147():149-158. PubMed ID: 29037976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the in vitro potential of celecoxib derivative AR-12 as an effective antiviral compound against four dengue virus serotypes.
    Hassandarvish P; Oo A; Jokar A; Zukiwski A; Proniuk S; Abu Bakar S; Zandi K
    J Antimicrob Chemother; 2017 Sep; 72(9):2438-2442. PubMed ID: 28666323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin derivatives as non-nucleoside inhibitors for dengue polymerase: molecular docking, molecular dynamics simulation, and binding free energy calculation.
    Anusuya S; Gromiha MM
    J Biomol Struct Dyn; 2017 Oct; 35(13):2895-2909. PubMed ID: 27608509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue.
    Amraiz D; Zaidi NU; Fatima M
    Enzyme Microb Technol; 2016 Oct; 92():26-30. PubMed ID: 27542741
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiviral Activity of Nordihydroguaiaretic Acid and Its Derivative Tetra-
    Merino-Ramos T; Jiménez de Oya N; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28507114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel 2-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,3,4-oxadiazole and 3-phenyl-5-[(E)-2-(thiophen-2-yl)ethenyl]-1,2,4-oxadiazole derivatives as dengue virus inhibitors targeting NS5 polymerase.
    Benmansour F; Eydoux C; Querat G; de Lamballerie X; Canard B; Alvarez K; Guillemot JC; Barral K
    Eur J Med Chem; 2016 Feb; 109():146-56. PubMed ID: 26774922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.
    Raut R; Beesetti H; Tyagi P; Khanna I; Jain SK; Jeankumar VU; Yogeeswari P; Sriram D; Swaminathan S
    Virol J; 2015 Feb; 12():16. PubMed ID: 25886260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct Activation of Adenosine Monophosphate-Activated Protein Kinase (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification of Host Cell Lipid Metabolism.
    Jiménez de Oya N; Blázquez AB; Casas J; Saiz JC; Martín-Acebes MA
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel model for the study of the therapy of flavivirus infections using the Modoc virus.
    Leyssen P; Van Lommel A ; Drosten C; Schmitz H; De Clercq E ; Neyts J
    Virology; 2001 Jan; 279(1):27-37. PubMed ID: 11145886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.